Group 1 - The core point of the article is the pricing and subscription details of the stock issuance by Shanghai Jianda Zhixin Medical Technology Group Co., Ltd, with a determined issuance price of 7.05 yuan per share, reflecting various financial metrics and investor participation [2][3][8]. Group 2 - After excluding invalid and highest bids, there were 278 participating investors, with a total subscription amount of 16,356,100,000 shares, resulting in a subscription multiple of 3,751.07 times [1][4]. - The determined issuance price corresponds to a price-to-earnings (P/E) ratio of 11.06 times based on the net profit attributable to the parent company for the year 2024, before non-recurring gains and losses [2][3]. - The company reported net profits of 191.32 million yuan for 2023 and 223.57 million yuan for 2024, meeting the listing standards of the Shenzhen Stock Exchange [3][6]. Group 3 - The effective subscription quantity from valid bids totaled 14,895,160,000 shares, with an effective subscription multiple of 3,416.02 times [4][11]. - The average static P/E ratio for the wholesale industry was reported at 25.73 times, indicating that the company's issuance price is significantly lower than the industry average [6][7]. - The strategic placement involved 6,300,000 shares allocated to the employee management plan, accounting for approximately 9.97% of the total issuance [8][10]. Group 4 - The subscription process for offline investors is set for September 16, 2025, with specific requirements for submitting bids and ensuring compliance with regulatory standards [12][13]. - The online subscription period is also scheduled for September 16, 2025, with a total initial issuance quantity of 10,110,500 shares available for public subscription [24][26]. - Investors must ensure their accounts meet the minimum market value requirements to participate in the online subscription [28][30].

山东黄金（600547）(600547.SH)发布公告，为进一步调整优化融资方式，公司结合资本市场整体运行 状况及已于近日成功实施H股配售的情况，于2025年9月12日召开第七届董事会第四次会议，审议通过 了《关于公司终止向特定对象发行A股股票事项并撤回申请文件的议案》，公司决定终止向特定对象发 行A股股票事项，并向上海证券交易所申请撤回相关申请文件。 ...

Core Viewpoint - NIO Inc. announced a stock issuance plan involving up to 181,818,190 Class A ordinary shares, with net proceeds intended for investment in core technologies for smart electric vehicles, development of future technology platforms and models, expansion of battery swapping and charging networks, strengthening the balance sheet, and general corporate purposes [1] Summary by Relevant Categories Investment in Technology - The company plans to use the net proceeds from the stock issuance to invest in the research and development of core technologies for smart electric vehicles [1] Future Development - Funds will also be allocated for the development of future technology platforms and vehicle models across its brands [1] Network Expansion - The company aims to expand its battery swapping and charging network as part of its growth strategy [1] Financial Strengthening - A portion of the proceeds will be used to further enhance the company's balance sheet strength [1] General Corporate Purposes - The remaining funds will be utilized for general corporate purposes [1]

蔚来汽车9月10日宣布拟进行一项股票发行计划，涉及公司总计不超过181,818,190股A类普通股。公司 目前计划将所得净收益用于投资智能电动汽车核心技术的研发，开发旗下各品牌的未来技术平台及车 型，扩展电池换电与充电网络，进一步增强资产负债表实力，并用于一般企业用途。 ...

Group 1 - The core announcement is that Sanofi Pharmaceutical-B plans to issue 17.3524 million subscription shares, representing approximately 14.16% of the company's enlarged issued share capital as of September 7, 2025 [2] - The subscription price is set at HKD 12 per share, which reflects a discount of about 19.84% compared to the closing price of HKD 14.97 on September 5 [2]

Core Viewpoint - Jixing New Energy (03395) plans to issue 12,891,250 shares at a subscription price of HKD 0.33 per share, representing approximately 2.15% of the enlarged issued share capital after the issuance, with a discount of about 5.71% compared to the closing price of HKD 0.35 on September 5, 2025 [1] Summary by Relevant Sections - **Subscription Details** - The company intends to issue 12,891,250 shares to subscribers [1] - The subscription price is set at HKD 0.33 per share, which is a discount of approximately 5.71% from the closing price on September 5, 2025 [1] - **Financial Implications** - The total expected proceeds from the subscription are approximately CAD 750,000 [1] - The net proceeds from the subscription are estimated to be around CAD 732,000 [1] - The net proceeds will be used for general working capital [1]

Core Viewpoint - WH Group's subsidiary Smithfield Foods is conducting a secondary offering of 19,531,698 shares at a price of $23.25 per share, with an additional option for underwriters to purchase up to 2,929,754 shares [1] Group 1 - The secondary offering is being executed by SFDS UK Holdings Limited, a wholly-owned subsidiary of WH Group [1] - Smithfield Foods will not sell any shares in the offering and will not receive any proceeds from the sale of shares by SFDS UK [1] - The offering is expected to be completed on September 8, 2025, subject to customary closing conditions [1] Group 2 - Morgan Stanley, BofA Securities, and Barclays are acting as joint book-running managers for the offering [1] - Goldman Sachs & Co. LLC, Citigroup, and BNP Paribas are serving as co-managers for the offering [1]

Group 1 - The number of valid subscription accounts for the online issuance was 13,178,223, with a total of 109,526,590,000 shares subscribed, resulting in an initial online subscription rate of 0.01277863% [1] - The total number of allocation numbers was 219,053,180, with a range from 100,000,000,000 to 100,219,053,179 [1] Group 2 - Due to an initial effective subscription multiple of approximately 7,825.56 times, which exceeded 100 times, the issuer and the lead underwriter decided to implement a reallocation mechanism [2] - After the reallocation mechanism was activated, the final number of shares issued offline was 6,998,000 shares, accounting for 20.00% of the total issuance after deducting the final strategic placement [2] - The final number of shares issued online was 27,992,000 shares, representing 80.00% of the total issuance after deducting the final strategic placement, with a final online subscription rate of 0.02555726% [2]

Core Viewpoint - Suzhou Huichuan United Power System Co., Ltd. has received approval for its initial public offering (IPO) and listing on the ChiNext board, with the underwriting managed by Guotai Junan Securities Co., Ltd. [1] Group 1: IPO Details - The IPO application has been approved by the Shenzhen Stock Exchange and registered by the China Securities Regulatory Commission [1] - The IPO will take place on September 15, 2025, with both offline and online subscription periods [2][17] - Investors do not need to pay subscription funds on the day of the IPO [17] Group 2: Subscription Process - Offline subscription will occur from 9:30 AM to 3:00 PM, while online subscription will be from 9:15 AM to 11:30 AM and 1:00 PM to 3:00 PM on the same day [2][17] - Investors must submit verification materials by September 9, 2025, to participate in the offline subscription [8] - The issuance will combine strategic placement, offline inquiry placement, and online issuance [2][3] Group 3: Investor Requirements - Offline investors must be registered securities companies, fund management companies, and other qualified institutional investors [5] - Minimum subscription amounts and asset requirements are set for both offline and online investors [15][16] - Investors must ensure their subscription amounts do not exceed their reported total assets [9][10] Group 4: Pricing and Allocation - The initial inquiry period for pricing is set for September 10, 2025 [6] - The pricing will be determined based on the inquiry results, with a mechanism to exclude invalid quotes [11][12] - The final issuance price will be disclosed in the issuance announcement [4] Group 5: Lock-up Period and Trading - For offline investors, 30% of the allocated shares will have a lock-up period of six months, while 70% will be tradable immediately [13][14] - Online investors will have no restrictions on the shares they acquire [13] Group 6: Risk Management - The underwriting process will be monitored by legal counsel to ensure compliance with regulations [12] - Investors are advised to understand the risks associated with investing in the ChiNext board, which includes high volatility and potential for loss [21]

上海建发致新医疗科技集团股份有限公司 首次公开发行股票并在创业板上市 初步询价及推介公告 保荐人（主承销商）：中信证券股份有限公司 特别提示 中信证券股份有限公司（以下简称"中信证券"或"保荐人（主承销商）"） 担任本次发行的保荐人（主承销商）。 本次发行的初步询价及网下发行均通过深交所网下发行电子平台（以下简称 "网下发行电子平台"）及中国证券登记结算有限责任公司深圳分公司（以下简 称"中国结算深圳分公司"）登记结算平台进行，请网下投资者认真阅读本公告。 关于初步询价和网下发行的详细内容，请查阅深交所网站（www.szse.cn）公布 的《网下发行实施细则》等相关规定。 敬请投资者重点关注本次发行方式、发行流程、回拨机制、网上网下申购 及缴款、弃购股份处理等方面，具体内容如下： 网下向符合条件的投资者询价配售（以下简称"网下发行"）和网上向持有深圳 市场非限售 A 股股份和非限售存托凭证市值的社会公众投资者定价发行（以下 简称"网上发行"）相结合的方式进行。 本次发行的战略配售、初步询价及网上、网下发行由保荐人（主承销商）负 责组织实施。初步询价及网下发行通过深交所网下发行电子平台 （https://eip ...